@article{9642a50e903f4c579d1c3c1ac748669f,
title = "COVID-19 among fit patients with CLL treated with venetoclax-based combinations",
keywords = "Aged, Antibodies, Monoclonal, Humanized/administration \& dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Betacoronavirus/isolation \& purification, Bridged Bicyclo Compounds, Heterocyclic/administration \& dosage, COVID-19, Coronavirus Infections/diagnosis, Female, Follow-Up Studies, Humans, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Male, Middle Aged, Pandemics, Pneumonia, Viral/diagnosis, Prognosis, Pyrazoles/administration \& dosage, Pyrimidines/administration \& dosage, Rituximab/administration \& dosage, SARS-CoV-2, Sulfonamides/administration \& dosage",
author = "Moritz F{\"u}rstenau and Petra Langerbeins and \{De Silva\}, Nisha and Fink, \{Anna Maria\} and Sandra Robrecht and \{von Tresckow\}, Julia and Florian Simon and Karin Hohloch and Jolanda Droogendijk and \{van der Klift\}, Marjolein and \{van der Spek\}, Ellen and Thomas Illmer and Bj{\"o}rn Sch{\"o}ttker and Kirsten Fischer and Wendtner, \{Clemens M\} and Eugen Tausch and Stephan Stilgenbauer and Niemann, \{Carsten U\} and Michael Gregor and Kater, \{Arnon P\} and Michael Hallek and Barbara Eichhorst",
year = "2020",
month = aug,
doi = "10.1038/s41375-020-0941-7",
language = "English",
volume = "34",
pages = "2225--2229",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "8",
}